866-997-4948(US-Canada Toll Free)

Pharmaceutical Business Confidence Report Q4 2013

Published By :

Kable Market Research

Published Date : Nov 2013

Category :

Pharmaceutical

No. of Pages : 43 Pages


Product Synopsis

“Pharmaceutical Business Confidence Report Q4 2013” is a new report by Kable that analyzes pharmaceutical industry executives\' views on the global economy, expectations on consumer confidence, supplier prices, key business concerns, and how executives\' future investments are set to change in Q4 2013. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance. Apart from providing access to the opinions and strategies of global pharmaceutical industry executives, it also examines their actions surrounding business priorities, threats and opportunities, and future investment areas over the next six months.

Introduction and Landscape

Why was the report written?

This report is the result of an extensive survey drawn from Kable\'s exclusive panel of leading global pharmaceutical industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the pharmaceutical industry, and forecasts company and industry growth prospects over the next six months. Furthermore, it also provides information about the impact of consumer confidence, supplier prices, and staff headcount likely to affect the investment decisions of the industry over the next six months.

What is the current market landscape and what is changing?

Overall, 66% and 50% of global pharmaceutical industry executives are optimistic about the future growth prospects of both their company and the industry over the next six months, respectively.

What are the key drivers behind recent market changes?

Optimism towards industry and company growth is driven by the improving global economic conditions, increasing in consumer spending, and the introduction of new products in the market.

What makes this report unique and essential to read?

“Pharmaceutical Business Confidence Report Q4 2013” is a new report by Kable that analyzes the industry sentiments globally on the latest economic and consumer issues and their impact upon investment decisions and growth prospects within the pharmaceutical industry. This report also examines the executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermore, it analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over the next six months. In addition, it provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over the next six months.

Key Features and Benefits

  • Project industry trends and industry growth expectations in the next six months, and understand business confidence to make informed business decisions.
  • The report drives revenues by understanding future product investment areas and key growth regions.
  • Readers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the growth prospects of the industry.
  • The report clearly forecasts the change in supplier prices of various products, which are likely to influence the industry\'s growth prospects over the next six months. 
  • Identifies the major changes in consumer confidence levels in the pharmaceutical industry over the next six months.

Key Market Issues

  • According to pharmaceutical industry respondents, the present economic conditions in the Middle East and Africa are deemed to be unfavourable.
  • New Government proposals/legislation, performance of North American economies, and the current state of the global economy are the key concerns among global pharmaceutical industry executives.
  • Overall, survey respondents forecast that supplier prices for semi-finished products will increase at an average of 3%, with those from Asia-Pacific expecting the biggest rise.
  • The majority of global pharmaceutical industry executives anticipate \'no change\' in consumer confidence in the industry, in the next six months.
  • Overall, industry executives exhibit high levels of optimism towards company growth prospects compared to industry growth prospects, in the next six months

Key Highlights

  • Overall, 49% of survey respondents anticipate a positive change in the global economic outlook over the next six months. 
  • Pharmaceutical industry executives plan to increase investments in the areas of new product development and marketing in the next six months.
  • Executives operating in Asia-pacific and North America anticipate the highest average increase, 5.1% and 4.0% respectively, in sales over the next six months.
  • Industry executives operating in Asia-Pacific and Europe anticipate an average increase of 2.7% and 2.5%, respectively, in their current workforce.
  • Executives operating across the globe consider \'increasing sales\', \'improving operational efficiency\', and \'new product development\' as key priorities over the next six months.

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Grass Pollen Allergy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

    Pollens are made up of tiny particles released by trees, plants and grasses during spring and summer as part of their reproductive cycle. Pollen owing to its fine particles can be easily inhaled by humans and animals which can cause significant irritation and inflammation to some people. Allergic rhinitis or hay fever is among the most common form of allergy caused by grass pollen. According to a study conducted by American College of Allergy, ...

  • Interferon Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    Interferons are a class of proteins generated and released by the host cells in response to the presence of pathogenic microbes such as bacteria, viruses, fungi and tumor cells. Interferons belong to a class of glycoproteins called cytokines and are referred to as first line defenders against microbial infections. Owing to presence of the ability to ‘interfere in viral cell replication’, these proteins fight against an infection by tr...

  • Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018

    The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American market for congestive heart failure treatment devices accounted for $1.6 billion in 2010 and is expected to reach $3.2 billion by the year 2016 at the CA...